MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202617054345 A) filed by Graviton Pharmaceuticals B. V. on April 29, 2026, for Rock2 Inhibitors In The Treatment Of Obesity.
Inventors include Waksal, Samuel D.; Wu, Rui; Forbes, Alexandria; Nussbaum, Ran; Feng, Lei; and Saengtawesin, Nicole.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: Provided herein, inter alia, are therapies using a Rho-associated coiled-coil containing protein kinase 2 (ROCK2) inhibitor and optionally a glucagon-like peptide 1 receptor (GLP- 1) agonist. The therapies may be used for treating type 2 diabetes and/or obesity and for promoting weight loss.
Disclaimer: Curated by HT Syndication.
